Bank of America
THRD

Bank of America’s Third Harmonic Bio THRD Stock Holding History

Bank of America’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-34,230
Closed -$186K – 8681
2025
Q2 		$186K Sell
34,230
-50,455
-60% -$252K ﹤0.01% 6212
2025
Q1 		$294K Buy
84,685
+43,387
+105% +$210K ﹤0.01% 5955
2024
Q4 		$425K Sell
41,298
-4,056
-9% -$50.5K ﹤0.01% 5669
2024
Q3 		$615K Buy
45,354
+12,415
+38% +$154K ﹤0.01% 5360
2024
Q2 		$428K Buy
32,939
+10,631
+48% +$131K ﹤0.01% 5437
2024
Q1 		$211K Sell
22,308
-1,406
-6% -$13.7K ﹤0.01% 5863
2023
Q4 		$260K Buy
23,714
+4,161
+21% +$33K ﹤0.01% 5923
2023
Q3 		$125K Sell
19,553
-799
-4% -$4.88K ﹤0.01% 6153
2023
Q2 		$97.9K Buy
20,352
+12,265
+152% +$58.4K ﹤0.01% 6212
2023
Q1 		$33.3K Sell
8,087
-4,110
-34% -$17.5K ﹤0.01% 6620
2022
Q4 		$52.4K Buy
+12,197
New +$204K ﹤0.01% 6465

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bank of America's THRD Position: Q3 2025 in Review

Bank of America sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 34,230 shares — an estimated $186K sold.

Bank of America first reported a position in THRD in Q4 2022 and held it in 11 quarters. The position peaked at $615K in Q3 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Bank of America reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Bank of America sold 34,230 Third Harmonic Bio shares in Q3 2025, an estimated $186K.
  • Bank of America first reported a position in Third Harmonic Bio in Q4 2022 and held it in 11 quarters.
  • Bank of America's Third Harmonic Bio position peaked at $615K in Q3 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Bank of America's 13F filing for Q3 2025, filed 14 Nov 2025.